3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Conditions
Breast Neoplasms
2433
Neoplasms
1842
Carcinoma, Non-Small-Cell Lung
1609
Prostatic Neoplasms
1312
Colorectal Neoplasms
1144
Lung Neoplasms
991
Neoplasm Metastasis
835
Multiple Myeloma
800
Leukemia, Myeloid, Acute
778
Ovarian Neoplasms
685
Pancreatic Neoplasms
671
Melanoma
667
Squamous Cell Carcinoma of Head and Neck
592
Carcinoma, Hepatocellular
570
Recurrence
568
Brain Neoplasms
528
Glioblastoma
519
Stomach Neoplasms
503
Head and Neck Neoplasms
502
Triple Negative Breast Neoplasms
473
Lymphoma
461
Uterine Cervical Neoplasms
457
Carcinoma, Renal Cell
429
Precursor Cell Lymphoblastic Leukemia-Lymphoma
421
Lymphoma, Non-Hodgkin
390
Endometrial Neoplasms
386
Sarcoma
369
Urinary Bladder Neoplasms
356
Lymphoma, Large B-Cell, Diffuse
356
Lymphoma, Follicular
356
Interventions
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Embolism
×
1 year
×
Clear all
NCT04657120
2025-12-23
HYDRA
Leiden University Medical Center
Phase NA
Completed
698 enrolled